NCT06373484 Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents
| NCT ID | NCT06373484 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre for Addiction and Mental Health |
| Condition | Disruptive Behavior Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-10-01 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2022-10-01 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will develop and test whether personalized profiles of children with Disruptive Behaviour Disorder (DBD) and their parents based on important psychological, emotional, and neuropsychological indicators predict their response to child cognitive behavioral treatment and Behavioral Parent Training.
Eligibility Criteria
Inclusion Criteria: * Child is borderline/clinically at risk on the Child Behaviour Checklist (CBCL) or Teacher Report Form (TRF) (T-score greater than or equal to 60 on Externalizing Problems composite scale or a T-score greater than or equal to 65 on the Oppositional Defiant Disorder and/or Conduct Disorder scales) * Child has clinically severe impairment in the interpersonal relations (greater than 3), functioning in schoolwork (greater than 3), or total domains (greater than 15) on the Columbia Impairment scale. * Parent is able and willing to participate in a group treatment Exclusion Criteria: * Child has an ongoing query or diagnosis of Pervasive Developmental Disorder or Autism or Asperger's Disorder * Evidence of cognitive delays or an intellectual disability (based on the Kauffman Brief Intelligence Test-2 (KBIT-2), verbal and/or IQ composite standard score below 80 or collateral information) * Child behaviour or emotional functioning that make group participation not possible * Child preference for individual treatment. * Parent behaviour or emotional functioning that make group participation not possible * Parent preference for individual treatment.
Contact & Investigator
Brendan F. Andrade, PhD
PRINCIPAL INVESTIGATOR
Centre for Addiction and Mental Health
Frequently Asked Questions
Who can join the NCT06373484 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Disruptive Behavior Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06373484 currently recruiting?
Yes, NCT06373484 is actively recruiting participants. Contact the research team at brendan.andrade@camh.ca for enrollment information.
Where is the NCT06373484 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT06373484 clinical trial?
NCT06373484 is sponsored by Centre for Addiction and Mental Health. The principal investigator is Brendan F. Andrade, PhD at Centre for Addiction and Mental Health. The trial plans to enroll 200 participants.